Beam Therapeutics News

Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results

May 7 19:14

Beam Therapeutics | DEFA14A: Others

Apr 20 04:25

Beam Therapeutics | DEF 14A: Definitive information statements

Apr 20 04:20

Beam Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 29 02:59

Beam Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 20:45

Beam Therapeutics | 8-K: Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones

Feb 27 19:45

Beam Therapeutics | 8-K: Current report

Jan 8 13:00

Beam Therapeutics | 8-K: Current report

Dec 15, 2023 05:05

Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results

Nov 8, 2023 20:00

Beam Therapeutics | 8-K: Current report

Oct 31, 2023 18:44

Beam Therapeutics | 8-K: Current report

Oct 19, 2023 20:50

Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results

Aug 8, 2023 19:11

Beam Therapeutics | 8-K: Current report

Jun 9, 2023 04:31

Beam Therapeutics | 8-K: Current report

May 11, 2023 04:56

Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results

May 10, 2023 19:00

Beam Therapeutics | DEFA14A: Others

Apr 22, 2023 04:11

Beam Therapeutics | DEF 14A: Definitive proxy statements

Apr 22, 2023 04:06

Beam Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 28, 2023 20:55

Beam Therapeutics | 8-K: Beam Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones

Feb 28, 2023 20:01

Beam Therapeutics | 8-K: Current report

Jan 9, 2023 20:09